Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma. - Wikidata - wikimedia - TriplyDB

Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma.

Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma.

http://www.wikidata.org/entity/Q37143946

about

Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer.miRNA-21 enhances chemoresistance to cisplatin in epithelial ovarian cancer by negatively regulating PTEN.Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.Research progress on the relationship between zinc deficiency, related microRNAs, and esophageal carcinoma.Medical examination powers miR-194-5p as a biomarker for postmenopausal osteoporosis.Low plasma levels of miR-101 are associated with tumor progression in gastric cancer.

P2860

Q28080153-D6BC2E78-9170-4F79-A464-C7EDF32140A8 Q33915812-5807A677-6616-45D9-98A0-8A6E85AC914B Q37641727-691FE94B-B305-43A4-AE42-6CE20F1299F7 Q38546133-525AD6B3-0398-410B-A970-2C6E509A4A33 Q39227002-C005C98B-9467-4FF2-AD9C-8F7DE5C0AC0C Q41143550-4550194F-48CA-4973-A89C-FC4AC84A2A0D Q42647010-F4DD2080-49D4-40CF-B51D-D7B95EBD14FD Q44089610-D061436B-3078-4793-B5F7-EA54AAD05F39 Q47094587-F1A528EB-353F-4B70-809D-046C276A9B98 Q47125854-9C3A522D-689F-4D16-8DDD-81B46E109D11

P2860

Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma.

http://www.wikidata.org/entity/Q37143946

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Circulating miR-21 as an indep ...... ageal squamous cell carcinoma.

@en

Circulating miR-21 as an indep ...... ageal squamous cell carcinoma.

@nl

type

label

Circulating miR-21 as an indep ...... ageal squamous cell carcinoma.

@en

Circulating miR-21 as an indep ...... ageal squamous cell carcinoma.

@nl

prefLabel

Circulating miR-21 as an indep ...... ageal squamous cell carcinoma.

@en

Circulating miR-21 as an indep ...... ageal squamous cell carcinoma.

@nl

P1433

Q37143946-F7B9C829-1F1A-47F8-A3E6-D18BB7F29475

P1476

Q37143946-A42F773B-18B8-4F3F-B49B-A668D761AF09

P2093

Q37143946-0B8802A1-81A8-41C8-86BB-5965A898BBC6

Q37143946-0C0ABC1A-D6B5-4038-BAF2-2E13E9C234CA

Q37143946-0D11C62C-C213-4258-A9F5-8E3E5EB81905

Q37143946-2FD442BB-19E3-4F38-8172-E4F258226890

Q37143946-5D00822F-1FFF-4C7D-9188-77E54AC30564

Q37143946-6D1E9852-283E-4F4A-B253-D227EC780192

Q37143946-73D9F3C7-A012-4C92-82B7-EEDE70BCD7E5

Q37143946-7508EA7D-285D-45C3-814E-7CD8321CAC81

Q37143946-B72D07B7-4538-4973-AAB7-08B888B41D48

Q37143946-CAD638B8-0A85-4958-9ECC-6BEC3A9B4695

P2860

Q37143946-0646377F-991F-4564-828C-E5B20D508912

Q37143946-072346AB-D212-4815-9456-9F004EF455AC

Q37143946-0BD49273-9F4C-4060-9BE7-9A07D258E588

Q37143946-0D457FF5-A77D-467A-B045-972F1A3F797B

Q37143946-1074BEB0-3F74-4699-B8E6-2646E2B15A5C

Q37143946-108A881D-DB06-49E2-A1B9-A2508C00FCA0

Q37143946-14CCDA23-AF2D-4102-ACC1-44D8E77257BE

Q37143946-1AACB6E4-3A61-417E-A6A9-7278E83D2126

Q37143946-1B6F4841-9316-4756-B384-10CE4A55F516

Q37143946-1D932762-281E-474E-BBC2-81BCD06E5ECB

P304

Q37143946-554B0617-E687-4D0A-BC5F-111BBA3B5AD6

P31

Q37143946-4B2C6BE4-E5F2-4FEC-96A2-58152580E3A2

P433

Q37143946-354EC1F2-5B66-4602-BED7-20F03A86A4DB

P478

Q37143946-644EE4DA-A14F-4C41-857B-597C3960D641

P577

Q37143946-65592FBD-FEBB-4EAA-83C0-362BEEEFC875

P698

Q37143946-FA5F35E0-FCF7-450E-9FEB-C39D3DA57A6E

P921

Q37143946-C75EA458-AD7A-4FA7-8C04-3BF51809066E

P932

Q37143946-0F604275-DC3F-4348-A5CF-BAAC3D2F375A

P1433

American Journal of Cancer Research

P1476

Circulating miR-21 as an indep ...... ageal squamous cell carcinoma.

@en

P2093

Atsushi Shiozaki

http://www.w3.org/2001/XMLSchema#string

Daisuke Ichikawa

http://www.w3.org/2001/XMLSchema#string

Eigo Otsuji

http://www.w3.org/2001/XMLSchema#string

Hirotaka Konishi

http://www.w3.org/2001/XMLSchema#string

Hitoshi Fujiwara

http://www.w3.org/2001/XMLSchema#string

Jun Kiuchi

http://www.w3.org/2001/XMLSchema#string

Kazuma Okamoto

http://www.w3.org/2001/XMLSchema#string

Mahito Miyamae

http://www.w3.org/2001/XMLSchema#string

Shuhei Komatsu

http://www.w3.org/2001/XMLSchema#string

Taisuke Imamura

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Foxo3a regulates apoptosis by negatively targeting miR-21

Secretory mechanisms and intercellular transfer of microRNAs in living cells

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)

Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells

Circulating microRNAs as stable blood-based markers for cancer detection.

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

P304

1511-1523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27508093

http://www.w3.org/2001/XMLSchema#string

P921

P932

4969400

http://www.w3.org/2001/XMLSchema#string